Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1090220107Completed
Open-label, single-arm trial of vecuronium, sponsored by Yasuyuki Sugi. Primary endpoints: Difference in neuromuscular recovery time to TOFR 0.7 between upper-limb EMG and lower-limb AMG and Difference in neuromuscular recovery time to TOFR 0.9 between upper-limb EMG and lower-limb AMG. Started Dec 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1090220107.